Walking ability and quality of life as outcome measures in a comparison of arterial reconstruction and leg amputation for the treatment of vascular disease  by Albers, Maximiano et al.
Eur J Vasc Endovasc Surg 11, 308-314 (1996) 
Walking Ability and Quality of Life as Outcome Measures in a 
Comparison of Arterial Reconstruction and Leg Amputation for the 
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Department of Surgery, Division of Vascular Surgery, University of Sdo Paulo Medical School, S~o Paulo, Brazil 
Objectives: To compare the walking ability and the quality of life of patients with severe limb ischaemia treated with an 
arterial reconstruction (AR) or a primary below-knee amputation (BKA). 
Design: A cohort study of patients with the first episode of ischaemia. 
Setting: University tertiary referral centre. 
Patients: Thirty-eight (AR 22, BKA 16) patients were studied over a 12-month period with a complete follow-up. 
Chief outcome measures: Walking ability was assessed with a subjective scale and quality of life was measured with the 
Spitzer QL-INDEX. The results were assessed for patients till alive (Step 1) as welt as for all patients (Step 2). 
Results: Walking ability was better in the AR group at 3 (OR = 10.37; CI 2.12, 50.74; p = 0.004), 6 (OR = 6.47; CI 1.83, 
22.79; p = 0.004), and 12 (OR = 3.82; CI 1.20, 12.15; p = 0.03) months. Quality of life was significantly better for AR 
patients at 3 (OR = 4.32; CI 1.55, 12.02; p = 0.005) and 6 (OR = 4.40; CI 1.68, 11.53; p = 0.003) months, but not at 12 
months (OR = 2.44; CI 0.95, 6.2& p = 0.06). The 12 month foot salvage rate was 68%. 
Conclusion: Walking ability and quality of life are better for AR patients than for BKA patients, even with a moderate foot 
salvage rate. 
Key Words: Arterial occlusive diseases; Quality of life; Walking ability; Bypass graft; Critical limb ischaemia. 
Introduction 
Arterial reconstruction for the treatment of severe 
limb ischaemia is performed to relieve rest pain, to 
promote ulcer healing, to limit tissue loss and to 
preserve bipedal gait. This procedure is therefore 
aimed at preserving or restoring the health-related 
quality of life to the best possible level. In this context, 
vascular surgeons have used outcome measures uch 
as functional health, 1 independent mobilit~ 2-s walk- 
ing ability, 2 and quality of life 2'6'7 as parameters for 
determining the success of intervention. As a result, 
there is already considerable body of information on 
the management of peripheral arterial dis- 
ease. 1'2'4'6'8-1° These measures may also be useful for 
decision analysis, B'7 economic evaluat iony '~2 and 
auditing, 1B activities in which arterial reconstruction is 
of particular interest. Since graft patency rates 
decrease with time, while the rehabilitation status of 
patients with an amputation often improves, 14 a 
*Please address all correspondence to: Maximiano Albers, MD, Rua 
Ministro God6i, 1584, apto 74, S~o Paulo, SP ZIP 05015-001, 
Brazil. 
comparison of arterial reconstruction and major 
amputation should be done over a reasonable period 
of time. The aim of this study on chronic severe leg 
ischaemia was therefore to carry out a 12 month 
comparison of the walking ability and the quality of 
life of patients undergoing an arterial reconstruction 
(AR) or a primary below-knee amputation (BKA). 
Patients and Methods 
Study &sign 
A cohort strategy was used to reduce selection bias, to 
evaluate multiple outcomes, and to assess the results 
repeatedly. The choice of a 12 month period of 
observation was based on other publications. 7'~s-~7 
Patient selection 
On a previous stud~ ~8 the walking ability and the 
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quality of life of 100 patients have been measured at 
baseline and reassessed 3, 6 and 12 months later, 
according to a standardised follow-up. The following 
entry criteria had been adopted: (1) an age of 40 years 
or more, (2) palpable femoral but absent pedal pulses, 
(3) the presence of rest pain, non-healing ulceration or 
gangrene, (4) no previous episode of severe ischaemia 
in the affected limb, and (5) the absence of cancer or 
mental disorders. The files of 38 of the original 100 
patients were used in this study and corresponded to
22 AR and 16 BKA performed within 60 days of 
entering the study. Sixty-two patients were not con- 
sidered in this study for various reasons, of which the 
most important was a physical handicap in 19 
(contralateral major amputation in 11; stroke in 8). 
Another 36 patients were excluded because of an 
alternative initial treatment (conservative manage- 
ment in 16, lumbar sympathectomy in 1, minor 
amputation in 12, through-knee amputation in 1, and 
above-knee amputation in 6). The remaining seven 
patients were excluded because they underwent arte- 
rial reconstruction or leg amputation more than 60 
days after initial assessment. 
Table 1. Risk factors and variables of interest at baseline 
AR group BKA group 
(n=22) (n=16) 
Age (years) 
Range 40~3 40-83 
First quartile 54 58 
Median 60.5 64 
Third quartile 70 70 
Men 16 11 
Smoking 16 9 
Diabetes 6 8 
Uraemia* 2 6 
Heart disease 10 10 
Infected ulcer / gangrene 7 9 
Ankle-pressure (mmHg) 
Range 30-110 0-90 
First quartile 40 35 
Median 50 50 
Third quartile 70 60 
Odds ratio 1.00 1.55 
QL-INDEX score 
Range 2-5 2-6 
First quartile 3 2.5 
Median 4 3 
Third quartile 5 6 
Odds ratio 1.00 1.41 
*p=0.05, Fisher exact est. 
Patient characteristics Table 2. Walking ability in subgroups AR1 and AR2, and in the 
BKA group (Step 1) 
There was no important difference between the two 
groups with regard to age and sex, or in the degree 
and extent of smoking, diabetes, heart disease, and 
foot infection. The difference in ankle systolic blood Walking 
pressure and in quality of life was also not important, ability 
However, the prevalence of an abnormal renal func- Absent 
tion was significantly higher in the BKA group than in Assisted 
the AR group (Table 1). Free 
Died 
Surgical treatment 
The 22 arterial bypass grafts consisted of one iliacofe- 
moral, 14 femoropopliteal (above-knee, 5; below-knee, 
9) and seven infrapopliteal (anterior tibial, 4; peroneal, 
3). Three AR patients required a secondary reconstruc- 
tion which included two femoropopliteal bypasses 
(above-knee, 1; below-knee, 1), and one thrombect- 
omy with reanastomosis. Of the 16 BKA patients, 11 
healed without complications while five underwent a
secondary amputation (below-knee, 1; through-knee, 
4). 
Outcome variables 
The chief outcome variables were walking ability and 
3 months 6 months  12 months 
AR BKA AR BKA AR BKA 
AR1 AR2 AR1 AR2 AR1 AR2 
4 4 14 1 4 10 1 3 7 
5 - 2 5 - 6 3 1 7 
6 - - 9 - - 9 1 2 
1 2 - 1 2 - 2 2 - 
3 months 6 months 12 months  
A. AR vs. BKA 
Odds ratio 10.37 6.47 3.82 
CI 2.12--50.74 1.83-22.79 1.20-12.15 
Chi-squared 8.344 8.436 5.147 
p-value 0.004 0.004 0.03 
B. AR1 vs. BKA 
Odds ratio 20.75 32.33 9.80 
C. AR2 vs. BKA 
Odds ratio nd nd 0.72 
nd, not determined. 
quality of life, but graft patencies, foot salvage, and 
patient survival were also assessed. 19Walking ability 
was classified as absent, assisted (the need for canes, 
frames or crutches), or free (no need for walking 
aids), 6 as shown in Table 2. Quality of life was 
measured with the Spitzer QL-INDEX. 2° This index is 
a simple, concise, valid and reliable tool for the overall 
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Table 3. QL-INDEX scoring for subgroups AR1 and AR2 and in the BKA group 
(Step 1) 
Baseline 3 months 6 months 12 months 
Score 
AR BKA AR BKA AR BKA AR BKA 
AR1 AR2 AR1 AR2 AR1 AR2 
1 . . . .  1 . . . . . .  
2 1 4 - 2 2 - 1 1 - 1 - 
3 8 5 - 1 1 - - 1 - 1 4 
4 8 2 1 1 8 - 3 6 - 3 3 
5 5 4 4 - 3 2 - 5 2 - 4 
6 - 1 5 1 2 3 3 - 2 
7 - - 2 - - 2 - - 2 - 3 
8 - - 2 - - 5 - - 4 - - 
9 . . . . .  2 - - 2 - - 
10 - - 1 - - 2 . . . . .  
A. AR vs. BKA 
Odds ratio 
CI 
Chi-squared 
p-value 
B. AR1 vs. BKA 
Odds ratio 
C. AR2 vs. BKA 
Odds ratio 
Baseline 3 months 6 months 12 months 
1.41 4.32 4.40 2.44 
0.54-3.63 1.55-12.02 1.68-11.53 0.95-6.26 
0.499 7.849 9.062 3.482 
0.48 0.005 0.003 0.06 
25.87 22.70 8.89 
0.21 0.15 0.22 
measurement  of qual i ty  of life and  can be admin-  
istered by  the vascu lar  surgeon h imsel f  in about  1 
min. 6 The index evaluates  five d imens ions:  (1) 
invo lvement  in own occupat ion  (Occupat ion),  (2) 
activit ies of da i ly  l iv ing (ADL), (3) percept ion  of own 
health (Health),  (4) suppor t  of fami ly  and  fr iends 
(Support) ,  and  (5) out look  on life (Outlook).  The 
t imef rame is the week  before examinat ion  and  each 
d imens ion  is scored 0, 1 or  2 so that the h ighest  
atta inable score is 10. One of the authors  (ACF), who  
was  not  invo lved  in pat ient  care, assessed all of the 38 
pat ients  dur ing  142 medica l  in terv iews w i th  100% 
complete  fo l low-up.  
Statistical analyses 
The Step 1 analys is  of wa lk ing  abi l i ty and  qual i ty  of 
life was  restr icted to pat ients  stil l al ive (Tables 2 and  
3). In Step 2, pat ients  a l ready  dead were also con- 
s idered when measur ing  qual i ty  of life, w i th  the last 
score obta ined  before death  used  at al l  t~-subsequent  
po ints  in t ime for wh ich  a reassessrff~nt had  been 
p lanned (Table 4). AR pat ients  were further  classi f ied 
into subgroups  AR1 (no major  amputat ion)  or  AR2 
(with a secondary  major  amputat ion)  to a l low for 
secondary  analysis.  A procedure  descr ibed by  Mor ton  
2~ and Dobson was  adopted  to compute  the odds  rat ios 
where  a~propr iate .  The use of 95% conf idence inter- 
vals (CI )~ and  hypothes is  test ing was  restr icted to the 
main  objectives. The Mann-Whi tney  test was  pre- 
ferred in order  to avo id  the assumpt ion  of normal i ty.  
Results 
Clinical course 
In the AR group,  the 12 month  cumulat ive  pr imary,  
secondary  and  ter t iary  graft patency  rate was  50, 54 
and  59%, respectively.  Of the 22 AR pat ients,  seven (2 
deaths)  had  no t issue loss, e ight underwent  minor  
amputat ion ,  f ive (1 death)  had  a be low-knee  amputa-  
tion, and  two (1 death)  had  an above-knee amputa-  
tion. At  12 months ,  the cumulat ive  foot sa lvage rate 
was  68% and the pat ient  surv iva l  rate was  82%. In the 
BKA group,  the final amputat ion  was  be low-knee  for 
12 pat ients  and  through-knee  for the other four, w i th  
no deaths.  
Walking ability 
Walk ing  abi l i ty improved w i th  t ime in both  the AR 
and  the BKA groups  but  was  s igni f icant ly better  for 
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Tab le  4. Q I~INDEX scoring for subgroups AR1 and AR2 and i n  the  BKA group 
(Step 2) 
Base l ine  3 months  6 months  12 months  
Score 
AR BKA AR BKA AR BKA AR BKA 
AR1 AR2 AR1 AR2 AR1 AR2 
1 . . . .  1 . . . . . .  
2 1 4 - 2 2 - 1 1 - 1 - 
3 8 5 - 2 1 - 1 1 - 2 4 
4 8 2 2 2 8 1 4 6 1 4 3 
5 5 4 4 - 3 2 - 5 2 - 4 
6 - 1 5 1 2 3 3 - 2 
7 - - 2 - - 2 - - 2 - 3 
8 - - 2 - - 5 - - 4 - - 
9 . . . . .  2 - - 2 - - 
10 - - 1 - - 2 - - 1 - - 
A. AR vs. BKA 
Odds  rat io  
C I  
Ch i - squared  
p -va lue  
B. AR1 vs. BKA 
Odds  rat io  
C. AR2 vs. BKA 
Odds  rat io  
Base l ine  3 months  6 months  12 months  
1.41 3.24 3.05 1.97 
0.54-3.63 1.23-8.57 1.19-7.85 0.82-4.76 
0.499 5.629 5.371 2.280 
0.48 0.02 0.02 0.13 
17.58 15.71 6.75 
0.27 0.15 0.21 
the AR group. The walking ability for BKA patients 
was worst at 3 months, but improved at 6 and 12 
months (Table 2). The walking ability in the BKA 
group was worse than in the AR1 subgroup but better 
than in the AR2 subgroup. Throughout he stud:~ 
however, the difference between AR1 and BKA 
patients decreased while that between AR2 and BKA 
patients increased. As a result, the overall difference 
between the AR and BKA groups decreased pro- 
gressively (Table 2). 
INDEX. Occupation showed the greatest increase in 
all the three assessments, with 7-11 out of 16 AR1 
patients achieving 1 or 2 points, while only one of 16 
BKA patients and none of the AR2 patients did the 
same. Support, on the other hand, was largely 
invariant, since almost all the patients achieved two 
points in all three assessments. Finally, the risk 
increased moderately for ADL and Outlook, but only 
a little for Health (Table 5). 
Quality of life 
There was a significantly worse quality of life for BKA 
patients at 3 and 6 months, but not at 12 months. The 
magnitude of the risk however, was always higher 
than the risk of 1.41 measured at baseline (Tables 3 and 
4). The quality of life in the BKA group was worse 
than in the AR1 subgroup, with a difference that 
decreased from three to 12 months. However, the 
quality of life was uniformly better in the BKA group 
than in the AR2 subgroup throughout he study. It 
must be remembered in this regard that the QL- 
INDEX score always reflects the summation of its 
individual components. 
The risk of a worse outcome in the BKA group was 
increased in four of the five dimensions of the QL- 
The confounding effect of renal function 
The risk of a worse walking ability in the BKA group 
was smaller for patients with abnormal renal function 
at 6 and 12 months. On the other hand, the risk of a 
worse quality of life in these patients was always 
greater. In both cases, however, the resulting con- 
founding effect was small (Table 6). 
Discussion 
Walking ability was better in the AR group than in the 
BKA group because of a much better outcome for AR1 
patients. However, some BKA patients had a better 
walking ability than certain AR1 patients (Table 2). 
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Table 5. Scores for the individual components of the QL-INDEX (Step 2) 
3 months  6months  12 months  
AR BKA AR BKA AR BKA 
Points AR1 AR2 AR1 AR2 AR1 AR2 
A. Occupation 
AR vs. BKA* 
B. ADL 
AR vs. BKA* 
C. Health 
AR vs. BKA* 
D. Support 
ARvs .  BKA* 
E. Outlook 
AR vs. BKA* 
0 9 6 15 5 6 15 6 7 15 
1 5 - 1 8 - 1 7 - 1 
2 2 - - 3 - - 2 - - 
7.13 15.27 10.54 
0 1 6 12 - 6 8 - 7 7 
1 12 - 4 9 - 8 10 - 9 
2 3 - - 7 - - 5 - - 
6.86 3.83 2.38 
0 1 4 2 1 2 1 1 1 2 
1 11 2 14 4 4 13 2 6 9 
2 4 - - 11 - 2 12 - 5 
1.28 2.65 1.80 
0 1 - 1 
1 1 - - 
2 16 6 14 16 6 16 15 7 15 
nd  nd  'nd  
0 - 2 3 - 1 2 - 2 3 
1 12 4 13 9 5 14 7 5 10 
2 4 - - 7 - - 8 - 3 
4.31 10.00 2.26 
nd, not determined.  
*The est imates are odds  ratios. 
Table 6. The  inf luence of  renal function on the r isk  o f  a worse  wa lk ing  ability or 
quality of life for BKA patients* 
Renal 
function 3 months  6 months  12 months  
A. Walkingability 
(Step 1) 
B. Qualityoflife 
(Step1) 
(Step 2) 
Normal  8.33 5.50 4.12 
Abnormal  nd  5.00 1.33 
All 10.37 6.47 3.82 
Normal  2.81 4.24 2.20 
Abnormal  nd  10.00 8.00 
All 4.32 4.40 2.44 
Normal  2.07 2.52 1.69 
Abnormal  nd  10.00 4.00 
All 3.24 2.63 1.97 
nd, not determined.  
*The est imates are odds  ratios. 
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Thus, foot salvage, an anatomical outcome, is not 
sufficient for a better physical rehabilitation. Similarly, 
walking ability, a physically related outcome, cannot 
capture other important aspects of human life. For this 
latter reason, a measure of quality of life is also 
desirable. 
Quality of life was better for the AR group, but the 
difference between AR and BKA patients was lower 
than it was in walking ability, probably as a result of 
the contribution of social and emotional domains. This 
finding therefore strengthens the need for considering 
health-related quality of life in the field of infra- 
inguinal arterial reconstruction. As for walking abilit3~ 
AR1 patients scored the highest for quality of life 
whereas AR2 scored the lowest. This result not only 
supports the belief that a failed bypass graft is more 
harmful than a primary amputation but also estimates 
the decreased risk of BKA in relation to AR2 at 12 
months as being 0.22 (Table 3) or 0.21 (Table 4). This 
latter finding is more related to some components of 
the QL-INDEX than to others. 
Occupation was the component most responsible 
for the difference in quality of life between AR and 
BKA patients. The wide difference in this dimension, 
observed within as early as 3 months, is in agreement 
with the opinion that the QL-INDEX would improve 
should Occupation be replaced by Independence on 
mobility, 23 a relevant dimension for patients with 
arterial disease. 2'24 Another problem was the invalid- 
ity and the insensitivity to change already identified 
for Support23"25; the other three dimensions conveyed 
more useful information. 
The fluctuations in ADL, Health, and Outlook 
reflected a good sensitivity to change, although they 
did not follow a uniform pattern throughout he 
study. In brief, all the components, except for Support, 
showed a lower increased risk for the BKA group at 12 
months, as was also observed for walking ability and 
quality of life. The changes in the individual compo- 
nents in the same direction as that of the global score 
is evidence for the appropriateness of the QL- 
INDEX.  26 Although this index should be modified, its 
current form still provides important information. The 
possibility of biased information, however, must be 
considered for any index or profile, particularly in 
nonrandomised comparisons. 
There are several indications that a sample selection 
bias was avoided in this study. First, the differences 
between the groups were reduced with a prospective 
design and strict entry criteria. Second, correcting for 
the increased risk of 1.41 for a worse quality of life at 
baseline would yield an odds ratio still greater than 
2.0 at 3 and 6 months and close to 1.40 at 12 months 
(Step 2). Third, the absence of deaths or above-knee 
amputations indicated that BKA patients had a lower 
risk than usual since the expected rate for these events 
was 11 and 22%, respectively. 3 Finally, the 18% 
mortality rate combined with the 59% tertiary graft 
patency rate at 12 months indicated that the AR 
patients were high risk. Although selection bias was 
unlikely, other forms of bias are worth considering. 
Our past experience with the QL-INDEX has been 
satisfactory, 6'18 but information bias dependent on this 
measuring tool or arising from the use of a single rater 
is impossible to evaluate. Indeed, there are conflicting 
findings on inter-observer agreement with the QL- 
INDEX and other tools. 2°'27 The fact that the rater in 
this study was a vascular surgeon is another potential 
source of bias. Although self-assessment of quality of 
life has been recommended, 26"27 we preferred to use 
interviews because of the limitations of old age, low 
literacy, and potential visual impairment. In addition, 
the advantages ofa maximal response rate, no missing 
items, and minimal errors of misunderstanding must 
also be considered. 2sFinally, sample distortion bias 
was avoided by using a standardised follow-up that 
was 100% complete. 
Confounding and chance also deserve some con- 
sideration. Confounding attributable to renal function 
in the association between treatment and chief out- 
comes was small. Furthermore, chance was not the 
explanation for the association between treatment and 
walking ability. This was also true for quality of life at 
3 and 6 months, although not at 12 months. Thus, in 
the absence of either bias the internal validity of this 
study was not compromised. The external validity 
also seems acceptable. 
In conclusion, arterial reconstruction has a favour- 
able influence on walking ability and quality of life 
when compared to primary leg amputation. This 
superiority depends heavily on avoiding a major 
amputation in most patients. These statements are 
valid only for the first episode of severe leg ischaemia 
in patients with an intact contralateral limb and free of 
stroke. 
The main implication arising from the results of this 
study is that measuring quality of life is promising as 
a uniform approach for testing the effectiveness of 
arterial reconstruction i situations in which a low 
foot salvage rate is expected. Such situations include 
multiple failed bypasses, advanced distal disease, 
patients at high risk or a combination of these. 29 For 
example, using the data shown in Table 4 we can 
estimate a 12 month foot salvage rate of 44% as the 
limit at which AR and BKA patients would have the 
same 12 month score for quality of life. This estimate 
is in disagreement with the 25% rate postulated on 
subjective grounds in a consensus document. 25
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